BYOMA Sensitive Retinol Oil by BYOMA
BYOMA

BYOMA Sensitive Retinol Oil

Oils

Safety score

Pregnancy-focused assessment

High Risk26/100
Higher concernLower concern

This formula contains a higher-risk ingredient in MamaSkin's current pregnancy-focused assessment.

Formula and assessment check

Ingredient safety review updated 24 November 2025. Product formulas can change, so compare the ingredients shown here with the packaging you have.

Report a formula mismatch

Ingredient breakdown

See how the listed formula falls across MamaSkin's pregnancy-focused risk bands.

10

No known risks

1

Low risk

0

Medium risk

1

High risk

Ingredients

Ingredients with a higher risk flag appear first, followed by the rest of the formula.

Hydroxypinacolone Retinoate

High Risk

Vitamin A derivative. Systemic retinoids are known teratogens, and topical retinoids are avoided during pregnancy due to class-wide risk and limited safety margins. Avoid use during pregnancy regardless of formulation.

Sources: EMA: Updated measures for pregnancy prevention during retinoid use https://www.ema.europa.eu/en/news/updated-measures-pregnancy-prevention-during-retinoid-use; FDA: Pregnancy and Lactation Labeling Rule https://www.fda.gov/drugs/labeling-information-drug-products/questions-and-answers-pregnancy-and-lactation-labeling-rule

Daucus Carota Sativa Seed Oil

Low Risk

Carrot seed oil is a steam-distilled essential oil rather than a conventional triglyceride plant oil. Pregnancy-specific topical data are limited, and the main cosmetic concerns are essential-oil irritation, sensitisation, and variable composition. MamaSkin applies its precautionary Low Risk essential-oil policy.

Sources: CIR plant-oil review materials identify Daucus Carota Sativa Seed Oil as an essential oil obtained by steam distillation https://www.cir-safety.org/sites/default/files/116_draft_oils.pdf; European Commission CosIng ingredient inventory; IFRA fragrance-safety resources.

Glycine Soja Oil

No Known Risks

Plant-derived emollient oil used to soften skin and support formula texture. Reviewed cosmetic safety sources support current cosmetic use, with no pregnancy- or breastfeeding-specific topical concern identified in the material reviewed.

Sources: CIR: Safety Assessment of Soy-Derived Ingredients as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory

Show all (12)

Helianthus Annuus Seed Oil

No Known Risks

Helianthus annuus (sunflower) seed oil is a common emollient rich in fatty acids and is generally well tolerated, with no known pregnancy or breastfeeding concerns in topical cosmetic use.

Sources: CIR; EU/UK Cosmetics Regulation

Dimethyl Isosorbide

No Known Risks

A solvent or preservative-support ingredient used to dissolve actives and stabilise a formula. No reproductive or pregnancy-specific signal was identified for the low concentrations used in finished topical cosmetics. Solvents can still increase local irritation or the delivery of other formula ingredients.

Sources: European Commission CosIng ingredient inventory; European Chemicals Agency substance information; published dermal and cosmetic-use data for dimethyl isosorbide, phenylpropanol and benzyl glycol.

Cetyl Ethylhexanoate

No Known Risks

Lightweight emollient ester used to improve slip and skin feel. Reviewed cosmetic ingredient references do not identify a pregnancy- or breastfeeding-specific concern for normal topical cosmetic use.

Sources: CIR cosmetic ingredient safety references for alkyl esters/emollient esters; EU CosIng / cosmetics regulatory inventory

Squalane

No Known Risks

Lightweight emollient used to support the skin barrier. Not associated with pregnancy-specific concerns at cosmetic exposure levels.

Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)

Caprylic/Capric Triglyceride

No Known Risks

Common emollient derived from fatty acids and glycerin. Used to soften skin and improve texture without pregnancy-specific concerns.

Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)

Bisabolol

No Known Risks

A terpene alcohol used for skin conditioning and soothing. Cosmetic safety reviewers reaffirmed bisabolol as safe at current cosmetic concentrations, and reproductive and developmental testing did not identify adverse effects. Bisabolol can increase skin penetration, so formulators should consider the safety of other ingredients in the same product.

Sources: CIR: Final Report on the Safety Assessment of Bisabolol https://cir-reports.cir-safety.org/view-attachment/?id=6fcf160b-8e74-ec11-8943-0022482f06a6; CIR re-review material https://www.cir-safety.org/sites/default/files/bisabolol.pdf

Camellia Oleifera Seed Oil

No Known Risks

A plant-derived fatty oil or butter used mainly as an emollient, conditioning ingredient or texture agent. Cosmetic safety reviewers concluded that the assessed plant-derived fatty acid oils are safe in current practices of use and concentration. This conclusion applies to cosmetic-grade fixed oils rather than similarly named volatile essential oils. Seed or food allergy may still matter for a susceptible person.

Sources: CIR: Safety Assessment of Plant-Derived Fatty Acid Oils as Used in Cosmetics https://cir-reports.cir-safety.org/view-attachment/?id=ad62ac6b-8e74-ec11-8943-0022482f06a6

Tocopherol

No Known Risks

Vitamin E antioxidant used to protect oils and support the skin barrier. Not associated with pregnancy-specific concerns at cosmetic exposure.

Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)

Magnolia Officinalis Bark Extract

No Known Risks

Magnolia bark extract may contain magnolol and honokiol. Developmental findings involve isolated honokiol delivered systemically at experimental doses and do not establish a hazard from the smaller, formulation-dependent exposure to a topical cosmetic extract.

Sources: PubMed: safety and toxicology review of magnolol and honokiol https://pubmed.ncbi.nlm.nih.gov/29925102/; PubMed: intravenous honokiol embryo-fetal study in rats https://pubmed.ncbi.nlm.nih.gov/26619782/; European Commission CosIng ingredient inventory.

Formulations can change without notice. For the most accurate result, compare this list with your packaging and scan the exact ingredient label in MamaSkin when you repurchase.

How to use this assessment

The risk band is the primary conclusion. The score adds detail within that band and should not be used to compare products as if a one-point difference were clinically meaningful.

MamaSkin provides pregnancy-focused information, not medical advice. Your midwife, GP, pharmacist or dermatologist should take priority when your circumstances differ from typical cosmetic use.

Read the full methodology